SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
 

For the month of October, 2018

Commission File Number 1565025

 

 

AMBEV S.A.
(Exact name of registrant as specified in its charter)
 

AMBEV S.A.
(Translation of Registrant's name into English)
 

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil
(Address of principal executive office)
 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 


Form 20-F ___X___ Form 40-F _______

  Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.  

Yes _______ No ___X____


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

(   ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

 

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

2,150,435

0.0137

0.0137

 

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (3)

Shares

Common

Direct with the Company

Conversion into ADRs

04

44,475

0.00

0.00

Shares

Common

Direct with the Company

Conversion into ADRs

19

51,284

0.00

0.00

 

 

 

Total Conversion ADRs (Sell)

 

95,759

 

0.00

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Exerc Options

21

30,125

R$ 9.35960

R$ 281,957.95

Shares

Common

Direct with the Company

Exerc Options

21

25,385

R$ 11.97200

R$ 303,909.22

Shares

Common

Direct with the Company

Exerc Options

21

29,125

R$ 17.19800

R$ 500,891.75

Shares

Common

Direct with the Company

Exerc Options

26

41,825

R$ 0.75648

R$ 31,639.78

 

 

 

Total Sell

 

126,460

 

R$ 1,118,398.70

 

 

 

 

 

 

 

 

Shares

Common

Direct with the Company

Plan of Shares Acquisition

21

42,696

R$ 18.85

R$ 804,819.60

 

 

 

Total Buy

 

42,696

 

R$ 804,819.60

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

Shares

Common

1,970,912

0.0125

0.0125

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)       Quantity multiplied by price .

 


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding  Shares in Treasury

 

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

 

Transac tions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (3)

Shares

Common

Direct with the Company

Conversion into ADRs

04

44,475

0,00

0,00

Shares

Common

Direct with the Company

Conversion into ADRs

19

51,284

0,00

0,00

 

 

 

Total Conversion ADRs (Buy)

 

95,759

 

0,00

 

 

 

 

 

 

 

 

ADR (*)

Common

Direct with the Company

Exerc Options

04

44,475

USD 0.971644

USD 43,213.87

ADR (*)

Common

Direct with the Company

Deferred ADRs

19

51,284

USD 1.531832

USD 78,558.47

 

 

 

Total Sell

 

95,759

 

USD 121,772.34

 

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

%

Same Class and Type

Total

ADR (*)

Common

0

0.0000

0.0000

 

(1)       When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3)       Quantity multiplied by price .

 

(*)    Each ADR is equivalent to 1 (one) share.

 

 

 


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Subsidiary Name: Ambev Luxembourg S.À.R.L.

Qualification: Position – Total Return Swap

 

Transac tions in the month

Securities / Derivatives

Securities Characteristics (1)

Intermediary

Operation

Day

Quantity (**)

Price

Volume (2)

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

24 (*)

1,411,700

R$ 18.39

R$ 25,961,163.00

Swap

Swap referenced in Shares

N/A

Total Return Swap Conclusion

27 (*)

1,450,000

R$ 18.48

R$ 26,796,000.00

 

 

 

Total operation

 

2,861,700

 

R$ 52,757,163.00

 

 

(1)       Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(2)       Quantity multiplied by price .

 

 

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(**) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.


 

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

 

In September 2018:

 

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

 

(  ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

 

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Position – Total Return Swap

 

Transac tions in the month

Securities / Derivatives

Securities Characteristics (1)

Intermediary

Operation

Day

Quantity (***)

Price

Volume (2)

Swap

ADR (*)

N/A

Total Return Swap Conclusion

18 (**)

8,692,628

USD 4.60160

USD 39,999,997.00

 

 

 

Total operation

 

8,692,628

 

USD 39,999,997.00

 

(1)     Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(2)       Quantity multiplied by price .

 

(*)    Each ADR is equivalent to 1 (one) share.

 

(**) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

 

(***) The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
Date: October 10, 2018
     
 
AMBEV S.A.
     
 
By: 
/s/ Fernando Mommensohn Tennenbaum
 
Fernando Mommensohn Tennenbaum
Chief Financial and Investor Relations Officer
 
 
 
 

Ambev (NYSE:ABEV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ambev Charts.
Ambev (NYSE:ABEV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ambev Charts.